5008752025-07-012025-09-305008752025-09-305008752025-03-315008752025-04-012025-09-305008752025-07-012025-09-30in-capmkt:OtherExpenses1Member5008752025-07-012025-09-30in-capmkt:OtherExpenses2Member5008752025-04-012025-09-30in-capmkt:OtherExpenses1Member5008752025-04-012025-09-30in-capmkt:OtherExpenses2Member5008752025-07-012025-09-30in-capmkt:ReportableSegments1Member5008752025-07-012025-09-30in-capmkt:ReportableSegments2Member5008752025-07-012025-09-30in-capmkt:ReportableSegments3Member5008752025-07-012025-09-30in-capmkt:ReportableSegments4Member5008752025-07-012025-09-30in-capmkt:ReportableSegments5Member5008752025-04-012025-09-30in-capmkt:ReportableSegments1Member5008752025-04-012025-09-30in-capmkt:ReportableSegments2Member5008752025-04-012025-09-30in-capmkt:ReportableSegments3Member5008752025-04-012025-09-30in-capmkt:ReportableSegments4Member5008752025-04-012025-09-30in-capmkt:ReportableSegments5Member5008752025-07-012025-09-30in-capmkt:ReportableSegments1Member5008752025-07-012025-09-30in-capmkt:ReportableSegments2Member5008752025-07-012025-09-30in-capmkt:ReportableSegments3Member5008752025-07-012025-09-30in-capmkt:ReportableSegments4Member5008752025-07-012025-09-30in-capmkt:ReportableSegments5Member5008752025-04-012025-09-30in-capmkt:ReportableSegments1Member5008752025-04-012025-09-30in-capmkt:ReportableSegments2Member5008752025-04-012025-09-30in-capmkt:ReportableSegments3Member5008752025-04-012025-09-30in-capmkt:ReportableSegments4Member5008752025-04-012025-09-30in-capmkt:ReportableSegments5Member5008752025-07-012025-09-30in-capmkt:ReportableSegments1Member5008752025-09-30in-capmkt:ReportableSegments1Member5008752025-07-012025-09-30in-capmkt:ReportableSegments2Member5008752025-09-30in-capmkt:ReportableSegments2Member5008752025-07-012025-09-30in-capmkt:ReportableSegments3Member5008752025-09-30in-capmkt:ReportableSegments3Member5008752025-07-012025-09-30in-capmkt:ReportableSegments4Member5008752025-09-30in-capmkt:ReportableSegments4Member5008752025-07-012025-09-30in-capmkt:ReportableSegments5Member5008752025-09-30in-capmkt:ReportableSegments5Member5008752025-07-012025-09-30in-capmkt:ReportableSegments1Member5008752025-09-30in-capmkt:ReportableSegments1Member5008752025-07-012025-09-30in-capmkt:ReportableSegments2Member5008752025-09-30in-capmkt:ReportableSegments2Member5008752025-07-012025-09-30in-capmkt:ReportableSegments3Member5008752025-09-30in-capmkt:ReportableSegments3Member5008752025-07-012025-09-30in-capmkt:ReportableSegments4Member5008752025-09-30in-capmkt:ReportableSegments4Member5008752025-07-012025-09-30in-capmkt:ReportableSegments5Member5008752025-09-30in-capmkt:ReportableSegments5Member5008752025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15008752025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15008752025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15008752025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500875ITCNOTLISTEDINE154A01025ITC LimitedMain BoardEquity2025-04-012026-03-312025-10-302025-10-16INRCroresQuarterlySecond quarterMulti segment2025-10-3013:20:002025-10-3016:10:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated21255860000058440000002184026000006577450000015657100000-17400000165449000002005000004348000000476526000001501602000006824240000088080000069123200000176940000002273000001792130000005120190000000066360000051865500000-13498000005051570000051261100000604400000499244000005913000001252710000014.094.09004.094.091. ‘Revenue from operations’ includes ‘Gross Revenue from sale of products and services’ and ‘Other operating revenue’. <BR> <BR> 2. ‘Purchase of stock-in-trade’ should be read as ‘Purchase of Stock-in-Trade and Biological Assets’. <BR> <BR> 3. ‘Changes in inventories of finished goods, work-in-progress and stock-in-trade’ should be read as ‘Changes in inventories of finished goods, Stock-in-Trade, work-in-progress, intermediates and Biological Assets’. <BR> <BR> 4. ‘Depreciation, depletion and amortisation expense’ should be read as ‘Depreciation and amortization expense’. <BR> <BR> NOTES TO STATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED 30.09.2025 <BR> <BR> 1. The Unaudited Consolidated Financial Results, Segment Results, Balance Sheet and Statement of Cash Flows were reviewed by the Audit Committee, and approved by the Board of Directors of the Company at its meeting held on 30th October, 2025. <BR> <BR> 2. The continuing significant brand building costs covering a range of personal care and branded packaged food products are reflected under 'Other expenses' stated above and in Segment Results under 'FMCG-Others'. <BR> <BR> 3. 95,88,290 Ordinary Shares of Re. 1/- each were issued and allotted under the Company’s Employee Stock Option Schemes during the quarter ended 30th September, 2025. Consequently, the issued and paid-up Share Capital of the Company stands increased to Rs. 1252,71,30,431/- as on 30th September, 2025. <BR> <BR> 4. Exceptional Items of Continuing Operations for the quarter and six months ended 30th September, 2025 represent final settlement of the insurance claim towards leaf tobacco stocks, which were destroyed due to fire at a third party owned warehouse in an earlier year. <BR> <BR> 5. Discontinued Operations represents operations of the Hotels Business of the Group (excluding ITC Grand Central, Mumbai) which was demerged pursuant to the Scheme of Arrangement amongst the Company and ITC Hotels Limited and their respective shareholders and creditors under Sections 230 to 232 read with the other applicable provisions of the Companies Act, 2013 (‘the Scheme’) w.e.f. 1st January, 2025, being the Appointed Date and the Effective Date of the Scheme. Comparative information has been presented accordingly. <BR> <BR> Brief particulars of the Discontinued Operations are given as under (Rs. in Crores): <BR> <BR> Sr. No. - Particulars - 3 Months ended 30.09.2025 (Unaudited) - Corresponding 3 Months ended 30.09.2024 (Unaudited) - Preceding 3 Months ended 30.06.2025 (Unaudited) - 6 Months ended 30.09.2025 (Unaudited) - 6 Months ended 30.09.2024 (Unaudited) – Twelve Months ended 31.03.2025 (Audited) <BR> <BR> a - Revenue from Operations - 0 – 770.90 – 0 – 0 – 1471.30 - 2484.58 <BR> b - Total Income - 0 – 776.13 – 0 – 0 – 1488.71 - 2517.16 <BR> c - Total Expenses - 0 – 667.19 – 0 – 0 – 1261.10 - 2002.67 <BR> d - Share of Profit / (Loss) of Associates and Joint Ventures - 0 – 3.97 – 0 – 0 – 7.82 - 11.35 <BR> e - Profit Before Exceptional Items and Tax (b-c+d) - 0 – 112.91 – 0 – 0 – 235.43 - 525.84 <BR> f - Exceptional Items - 0 – (1.15) – 0 – 0 – (4.19) - 15128.81 <BR> g - Tax Expenses - 0 – 36.47 – 0 – 0 – 71.28 - 638.64 <BR> h - Profit from Discontinued Operations (e+f-g) - 0 – 75.29 – 0 – 0 – 159.96 - 15016.01 <BR> <BR> 6. The amalgamation of Sresta Natural Bioproducts Private Limited (SNBPL) and Wimco Limited, wholly owned subsidiaries, with the Company was approved by the Board of Directors on 1st August, 2025. The process of seeking approval for the said amalgamation from the National Company Law Tribunal, Kolkata and Hyderabad Benches, is in progress. <BR> <BR> The fair values of assets and liabilities on acquisition of SNBPL and its subsidiaries Fyve Elements LLC, USA and Sresta Global FZE, UAE have been provisionally determined and recorded in accordance with Ind AS 103 on 'Business Combinations' and are reflected in 'FMCG- Others' segment. The financial results of the Group and 'FMCG-Others' segment include those of SNBPL and its subsidiaries with effect from 13th June, 2025. Accordingly, results of the quarter and six months ended 30th September, 2025 are not comparable with previous periods. <BR> <BR> 7. This statement is as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> 2025-04-012025-09-30UnauditedConsolidated443852100000126661000004565182000001281575000005459900000096250000033303400000365200000857760000091718100000317683300000138834900000880800000139715700000350799000006874000003576730000001039484000000001351200000105299600000791000000106090600000103703100000159650000010450720000015834000001252710000018.288.27008.288.27Excise Duty17542300000Other Expenses30110300000Excise Duty33887900000Other Expenses578302000001727870000001305010000031607000001006460000032389800000345400000050277900000130066600000064300000551310000013564400000010719000001645050000043524190000018762590000014513560000065033800000484200000035621600000612000001459750000026529170000001986710000047278470000000908026600000125271000006981945000007107216000005227200000715948800000000066410000006641000000315500000026494900000041830000036709200000157370000021714000004940820000051579600000184867000007164000000064031500000930200000187669000000155368600000001920778000009080266000001. ‘Other non-current assets’ includes ‘Right of Use assets’ of Rs. 525.37 Crores, ‘Income Tax Assets (Net)’ of Rs. 25.09 Crores, and ‘Other non-current assets’ of Rs. 1094.59 Crores. <BR> <BR> 2. ‘Other current assets’ includes ‘Biological assets other than bearer plants’ of Rs. 221.25 Crores and ‘Other current assets’ of Rs. 1765.46 Crores. <BR> <BR> 3. ‘Other non-current financial liabilities’ includes ‘Lease liabilities’ of Rs. 144.05 Crores and ‘Other financial liabilities’ of Rs. 520.05 Crores. <BR> <BR> 4. ‘Other current financial liabilities’ includes ‘Lease liabilities’ of Rs. 61.55 Crores and ‘Other financial liabilities’ of Rs. 1787.12 Crores. <BR> FMCG - Cigarettes94143400000FMCG - Others60591200000Agri Business40378000000Paperboards, Paper & Packaging22203200000Others12446200000FMCG - Cigarettes189682000000FMCG - Others118595600000Agri Business137616400000Paperboards, Paper & Packaging43369400000Others242721000002297620000005135355000001928750000072986100000210474500000440549400000FMCG - Cigarettes54621000000FMCG - Others4387200000Agri Business4536100000Paperboards, Paper & Packaging1813900000Others1826500000FMCG - Cigarettes109610300000FMCG - Others8377500000Agri Business8882800000Paperboards, Paper & Packaging3327900000Others337530000067184700000133573800000200500000365200000-2802600000-785830000069786800000141066900000FMCG - Cigarettes115047200000FMCG - Others157893800000Agri Business95895900000Paperboards, Paper & Packaging100241400000Others31766500000500844800000407181800000908026600000FMCG - Cigarettes65941600000FMCG - Others29213500000Agri Business15892400000Paperboards, Paper & Packaging13234100000Others10381400000134663000000574148000001920778000001. ‘Revenue from operations’ should be read as ‘Gross Revenue from sale of products and services’. <BR> <BR> 2. ‘Other Unallocable Expenditure net off Unallocable income’ should be read as ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’. <BR> <BR> 3. In case of 3 months ended 30.09.2025, ‘Other Unallocable Expenditure net off Unallocable income’ includes ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’ of Rs. (125.82) Crores, Exceptional Items* of Rs. (88.08) Crores and Share of Profit / (Loss) of associates and joint ventures of Rs. 66.36 Crores. <BR> <BR> 4. In case of 6 months ended 30.09.2025, ‘Other Unallocable Expenditure net off Unallocable income’ includes ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’ of Rs. (562.63) Crores, Exceptional Items* of Rs. (88.08) Crores and Share of Profit / (Loss) of associates and joint ventures of Rs. 135.12 Crores. <BR> <BR> 5. In case of 3 months ended 30.09.2025 and 6 months ended 30.09.2025, ‘Un-allocable Assets’ includes Nil ‘Discontinued Operations**’ and ‘Unallocated Corporate Assets’ of Rs. 40718.18 Crores. <BR> <BR> 6. In case of 3 months ended 30.09.2025 and 6 months ended 30.09.2025, ‘Un-allocable Liabilities’ includes Nil ‘Discontinued Operations**’ and ‘Unallocated Corporate Liabilities’ of Rs. 5741.48 Crores. <BR> <BR> * Refer Note 4 to the Consolidated Financial Results. <BR> ** Refer note 5 to the Consolidated Financial Results. <BR> <BR> Note: As stock options and stock appreciation linked reward units are granted to align the interests of employees with those of shareholders and also to attract and retain talent for the Group as a whole, the charge thereof do not form part of the segment performance reviewed by the Corporate Management Committee.365200000-32443500000-196887000000000002890600000000857760000000000-2391000001514000006350900000639300000-528460000000194520000000-4974030000089975400000000283494000000616260000000030451000000027384190000000001125000001062090000000000000000001530000061500000004433000004307700000078306000003278750000000348140000000000597400000476600000324400000982708000003690000005200000-97300000-95464500000-10510000000-105100000058933000004842300000Items that will not be reclassified to profit or loss-1046900000-1046900000Items that will not be reclassified to profit or loss823200000823200000-142500000129400000Items that will be reclassified to profit or loss-799100000-799100000Items that will be reclassified to profit or loss-173800000-173800000-353700000-271000000-1349800000791000000